Skip to main content
Top
Published in: Tumor Biology 4/2016

01-04-2016 | Original Article

Esculetin, a natural coumarin compound, evokes Ca2+ movement and activation of Ca2+-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells

Authors: Hong-Tai Chang, Chiang-Ting Chou, You-Sheng Lin, Pochuen Shieh, Daih-Huang Kuo, Chung-Ren Jan, Wei-Zhe Liang

Published in: Tumor Biology | Issue 4/2016

Login to get access

Abstract

Esculetin (6,7-dihydroxycoumarin), a derivative of coumarin compound, is found in traditional medicinal herbs. It has been shown that esculetin triggers diverse cellular signal transduction pathways leading to regulation of physiology in different models. However, whether esculetin affects Ca2+ homeostasis in breast cancer cells has not been explored. This study examined the underlying mechanism of cytotoxicity induced by esculetin and established the relationship between Ca2+ signaling and cytotoxicity in human breast cancer cells. The results showed that esculetin induced concentration-dependent rises in the intracellular Ca2+ concentration ([Ca2+]i) in ZR-75-1 (but not in MCF-7 and MDA-MB-231) human breast cancer cells. In ZR-75-1 cells, this Ca2+ signal response was reduced by removing extracellular Ca2+ and was inhibited by the store-operated Ca2+ channel blocker 2-aminoethoxydiphenyl borate (2-APB). In Ca2+-free medium, pre-treatment with the endoplasmic reticulum Ca2+ pump inhibitor thapsigargin (TG) abolished esculetin-induced [Ca2+]i rises. Conversely, incubation with esculetin abolished TG-induced [Ca2+]i rises. Esculetin induced cytotoxicity that involved apoptosis, as supported by the reduction of mitochondrial membrane potential and the release of cytochrome c and the proteolytic activation of caspase-9/caspase-3, which were partially reversed by pre-chelating cytosolic Ca2+ with 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid-acetoxymethyl ester (BAPTA-AM). Moreover, esculetin increased the percentage of cells in G2/M phase and regulated the expressions of p53, p21, CDK1, and cyclin B1. Together, in ZR-75-1 cells, esculetin induced [Ca2+]i rises by releasing Ca2+ from the ER and causing Ca2+ influx through 2-APB-sensitive store-operated Ca2+ entry. Furthermore, esculetin activated Ca2+-associated mitochondrial apoptotic pathways that involved G2/M cell cycle arrest.
Literature
1.
go back to reference DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.CrossRefPubMed DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62.CrossRefPubMed
2.
go back to reference Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1–22.CrossRefPubMed Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol. 2007;608:1–22.CrossRefPubMed
3.
go back to reference Moghadamtousi SZ, Goh BH, Chan CK, Shabab T, Kadir HA. Bio-logical activities and phytochemicals of Swietenia macrophylla King. Molecules. 2013;18:10465–83.CrossRefPubMed Moghadamtousi SZ, Goh BH, Chan CK, Shabab T, Kadir HA. Bio-logical activities and phytochemicals of Swietenia macrophylla King. Molecules. 2013;18:10465–83.CrossRefPubMed
4.
go back to reference Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397–421.CrossRefPubMed Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006;71:1397–421.CrossRefPubMed
5.
go back to reference Khan MK, Zill EH, Dangles O. A comprehensive review on flavanones, the major citrus polyphenols. J Food Compos Anal. 2014;33:85–104.CrossRef Khan MK, Zill EH, Dangles O. A comprehensive review on flavanones, the major citrus polyphenols. J Food Compos Anal. 2014;33:85–104.CrossRef
6.
go back to reference Chang WS, Lin CC, Chuang SC, Chiang HC. Superoxide anion scavenging effect of coumarins. Am J Chin Med. 1996;24:11–7.CrossRefPubMed Chang WS, Lin CC, Chuang SC, Chiang HC. Superoxide anion scavenging effect of coumarins. Am J Chin Med. 1996;24:11–7.CrossRefPubMed
7.
go back to reference Tubaro A, Del Negro P, Ragazzi E, Zampiron S, Della LR. Anti-inflammatory and peripheral analgesic activity of esculetin in vivo. Pharmacol Res Commun. 1988;20:83–5.CrossRefPubMed Tubaro A, Del Negro P, Ragazzi E, Zampiron S, Della LR. Anti-inflammatory and peripheral analgesic activity of esculetin in vivo. Pharmacol Res Commun. 1988;20:83–5.CrossRefPubMed
8.
go back to reference Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev. 1990;22:503–29.CrossRefPubMed Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD. The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev. 1990;22:503–29.CrossRefPubMed
9.
go back to reference Vitaglione P, Morisco F, Caporaso N, Fogliano V. Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr. 2004;44:575–86.CrossRefPubMed Vitaglione P, Morisco F, Caporaso N, Fogliano V. Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr. 2004;44:575–86.CrossRefPubMed
10.
go back to reference Lacy A, O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des. 2004;10:3797–811.CrossRefPubMed Lacy A, O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des. 2004;10:3797–811.CrossRefPubMed
11.
go back to reference Wang CJ, Hsieh YJ, Chu CY, Lin YL, Tseng TH. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 2002;183:163–8.CrossRefPubMed Wang CJ, Hsieh YJ, Chu CY, Lin YL, Tseng TH. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 2002;183:163–8.CrossRefPubMed
12.
go back to reference Kok SH, Yeh CC, Chen ML, Kuo MY. Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncol. 2009;45:1067–72.CrossRefPubMed Kok SH, Yeh CC, Chen ML, Kuo MY. Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncol. 2009;45:1067–72.CrossRefPubMed
13.
go back to reference Rubio V, Calviño E, García-Pérez A, Herráez A, Diez JC. Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism. Chem Biol Interact. 2014;220:129–39.CrossRefPubMed Rubio V, Calviño E, García-Pérez A, Herráez A, Diez JC. Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism. Chem Biol Interact. 2014;220:129–39.CrossRefPubMed
14.
go back to reference Kim AD, Han X, Piao MJ, Hewage SR, Hyun CL, Cho SJ, et al. Esculetin induces death of human colon cancer cells via the reactive oxygen species-mediated mitochondrial apoptosis pathway. Environ Toxicol Pharmacol. 2015;39:982–9.CrossRefPubMed Kim AD, Han X, Piao MJ, Hewage SR, Hyun CL, Cho SJ, et al. Esculetin induces death of human colon cancer cells via the reactive oxygen species-mediated mitochondrial apoptosis pathway. Environ Toxicol Pharmacol. 2015;39:982–9.CrossRefPubMed
15.
go back to reference Earashi M, Noguchi M, Tanaka M. In vitro effects of eicosanoid synthesis inhibitors in the presence of linoleic acid on MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 1996;37:29–37.CrossRefPubMed Earashi M, Noguchi M, Tanaka M. In vitro effects of eicosanoid synthesis inhibitors in the presence of linoleic acid on MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 1996;37:29–37.CrossRefPubMed
18.
19.
20.
go back to reference Tang S, Wang X, Shen Q, Yang X, Yu C, Cai C, et al. Mitochondrial Ca2+ uniporter is critical for store-operated Ca2+ entry-dependent breast cancer cell migration. Biochem Biophys Res Commun. 2015;458:186–93.CrossRefPubMed Tang S, Wang X, Shen Q, Yang X, Yu C, Cai C, et al. Mitochondrial Ca2+ uniporter is critical for store-operated Ca2+ entry-dependent breast cancer cell migration. Biochem Biophys Res Commun. 2015;458:186–93.CrossRefPubMed
21.
go back to reference Bootman M. Intracellular calcium. Questions about quantal Ca2+ release. Curr Biol. 1994;4:169–72.CrossRefPubMed Bootman M. Intracellular calcium. Questions about quantal Ca2+ release. Curr Biol. 1994;4:169–72.CrossRefPubMed
22.
23.
go back to reference Azimi I, Roberts-Thomson SJ, Monteith GR. Calcium influx pathways in breast cancer: opportunities for pharmacological intervention. Br J Pharmacol. 2014;171:945–60.CrossRefPubMedPubMedCentral Azimi I, Roberts-Thomson SJ, Monteith GR. Calcium influx pathways in breast cancer: opportunities for pharmacological intervention. Br J Pharmacol. 2014;171:945–60.CrossRefPubMedPubMedCentral
24.
go back to reference Evan GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr Opin Cell Biol. 1995;7:825–34.CrossRefPubMed Evan GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr Opin Cell Biol. 1995;7:825–34.CrossRefPubMed
25.
go back to reference King KL, Cidlowsky JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem. 1995;58:175–80.CrossRefPubMed King KL, Cidlowsky JA. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem. 1995;58:175–80.CrossRefPubMed
26.
go back to reference Harper JW, Elledge SJ. Cdk inhibitors in development and cancer. Curr Opin Genet Dev. 1996;6:56–84.CrossRefPubMed Harper JW, Elledge SJ. Cdk inhibitors in development and cancer. Curr Opin Genet Dev. 1996;6:56–84.CrossRefPubMed
28.
go back to reference Bold RJ, Ishizuka J, Yao CZ, Townsend Jr CM, Thompson JC. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status. Anticancer Res. 1998;18:4051–6.PubMed Bold RJ, Ishizuka J, Yao CZ, Townsend Jr CM, Thompson JC. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptors status. Anticancer Res. 1998;18:4051–6.PubMed
29.
go back to reference Chang HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK, et al. Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells. Breast Cancer Res Treat. 2002;71:125–31.CrossRefPubMed Chang HT, Huang JK, Wang JL, Cheng JS, Lee KC, Lo YK, et al. Tamoxifen-induced increases in cytoplasmic free Ca2+ levels in human breast cancer cells. Breast Cancer Res Treat. 2002;71:125–31.CrossRefPubMed
30.
go back to reference Chang HT, Chou CT, Kuo DH, Shieh P, Jan CR, Liang WZ. The mechanism of Ca2+ movement in the involvement of baicalein-induced cytotoxicity in ZR-75-1 human breast cancer cells. J Nat Prod. 2015;78:1624–34.CrossRefPubMed Chang HT, Chou CT, Kuo DH, Shieh P, Jan CR, Liang WZ. The mechanism of Ca2+ movement in the involvement of baicalein-induced cytotoxicity in ZR-75-1 human breast cancer cells. J Nat Prod. 2015;78:1624–34.CrossRefPubMed
31.
go back to reference Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–50.PubMed Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–50.PubMed
32.
go back to reference Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271–9.CrossRefPubMed Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271–9.CrossRefPubMed
33.
go back to reference Chen YT, Chen YF, Chiu WT, Wang YK, Chang HC, Shen MR. The ER Ca2+ sensor STIM1 regulates actomyosin contractility of migratory cells. J Cell Sci. 2013;126:1260–7.CrossRefPubMed Chen YT, Chen YF, Chiu WT, Wang YK, Chang HC, Shen MR. The ER Ca2+ sensor STIM1 regulates actomyosin contractility of migratory cells. J Cell Sci. 2013;126:1260–7.CrossRefPubMed
34.
go back to reference Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem. 2010;285:19173–83.CrossRefPubMedPubMedCentral Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem. 2010;285:19173–83.CrossRefPubMedPubMedCentral
35.
go back to reference Yoon MJ, Lee AR, Jeong SA, Kim YS, Kim JY, Kwon YJ, et al. Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells. Oncotarget. 2014;5:6816–31.CrossRefPubMedPubMedCentral Yoon MJ, Lee AR, Jeong SA, Kim YS, Kim JY, Kwon YJ, et al. Release of Ca2+ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells. Oncotarget. 2014;5:6816–31.CrossRefPubMedPubMedCentral
36.
go back to reference Kumar B, Kumar A, Ghosh S, Pandey BN, Mishra KP, Hazra B. Diospyrin derivative, an anticancer quinonoid, regulates apoptosis at endoplasmic reticulum as well as mitochondria by modulating cytosolic calcium in human breast carcinoma cells. Biochem Biophys Res Commun. 2012;417:903–9.CrossRefPubMed Kumar B, Kumar A, Ghosh S, Pandey BN, Mishra KP, Hazra B. Diospyrin derivative, an anticancer quinonoid, regulates apoptosis at endoplasmic reticulum as well as mitochondria by modulating cytosolic calcium in human breast carcinoma cells. Biochem Biophys Res Commun. 2012;417:903–9.CrossRefPubMed
37.
go back to reference Noguchi M, Earashi M, Minami M, Miyazaki I, Tanaka M, Sasaki T. Effects of piroxicam and esculetin on the MDA-MB-231 human breast cancer cell line. Prostaglandins Leukot Essent Fat Acids. 1995;53:325–9.CrossRef Noguchi M, Earashi M, Minami M, Miyazaki I, Tanaka M, Sasaki T. Effects of piroxicam and esculetin on the MDA-MB-231 human breast cancer cell line. Prostaglandins Leukot Essent Fat Acids. 1995;53:325–9.CrossRef
38.
go back to reference Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry. 1980;19:2396–404.CrossRefPubMed Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry. 1980;19:2396–404.CrossRefPubMed
39.
go back to reference Poulin R, Lessard M, Zhao C. Inorganic cation dependence of putrescine and spermidine transport in human breast cancer cells. J Biol Chem. 1995;270:1695–704.CrossRefPubMed Poulin R, Lessard M, Zhao C. Inorganic cation dependence of putrescine and spermidine transport in human breast cancer cells. J Biol Chem. 1995;270:1695–704.CrossRefPubMed
40.
go back to reference Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000;10:369–77.CrossRefPubMed Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 2000;10:369–77.CrossRefPubMed
41.
go back to reference Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132–6.CrossRefPubMed Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275:1132–6.CrossRefPubMed
42.
go back to reference O’Connell MJ, Walworth NC, Carr AM. The G2-phase DNA-damage checkpoint. Trends Cell Biol. 2000;10:296–303.CrossRefPubMed O’Connell MJ, Walworth NC, Carr AM. The G2-phase DNA-damage checkpoint. Trends Cell Biol. 2000;10:296–303.CrossRefPubMed
43.
go back to reference Lee KC, Chou KJ, Cheng JS, Wang JL, Tang KY, Tseng LL, et al. Novel effects of 5,8,11-eicosatriynoic acid, a lipoxygenase inhibitor, on Ca2+ mobilization in Madin Darby canine kidney cells. Pharmacol Toxicol. 2001;88:20–6.CrossRefPubMed Lee KC, Chou KJ, Cheng JS, Wang JL, Tang KY, Tseng LL, et al. Novel effects of 5,8,11-eicosatriynoic acid, a lipoxygenase inhibitor, on Ca2+ mobilization in Madin Darby canine kidney cells. Pharmacol Toxicol. 2001;88:20–6.CrossRefPubMed
44.
go back to reference Yamamura H, Nagano N, Hirano M, Muraki K, Watanabe M, Imaizumi Y. Activation of Ca2+-dependent K+ current by nordihydroguaiaretic acid in porcine coronary arterial smooth muscle cells. J Pharmacol Exp Ther. 1999;291:140–6.PubMed Yamamura H, Nagano N, Hirano M, Muraki K, Watanabe M, Imaizumi Y. Activation of Ca2+-dependent K+ current by nordihydroguaiaretic acid in porcine coronary arterial smooth muscle cells. J Pharmacol Exp Ther. 1999;291:140–6.PubMed
45.
go back to reference Lee KL, Dai Q, Hansen EL, Saner CN, Price TM. Modulation of ATP-induced calcium signaling by progesterone in T47D-Y breast cancer cells. Mol Cell Endocrinol. 2010;319:109–15.CrossRefPubMedPubMedCentral Lee KL, Dai Q, Hansen EL, Saner CN, Price TM. Modulation of ATP-induced calcium signaling by progesterone in T47D-Y breast cancer cells. Mol Cell Endocrinol. 2010;319:109–15.CrossRefPubMedPubMedCentral
46.
go back to reference Le Bihan S, Marsaud V, Mercier-Bodard C, Baulieu EE, Mader S, White JH, et al. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Mol Endocrinol. 1998;12:986–1001.CrossRefPubMed Le Bihan S, Marsaud V, Mercier-Bodard C, Baulieu EE, Mader S, White JH, et al. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells. Mol Endocrinol. 1998;12:986–1001.CrossRefPubMed
47.
go back to reference McAndrew D, Grice DM, Peters AA, Davis FM, Stewart T, Rice M, et al. ORAI1-mediated calcium influx in lactation and in breast cancer. Mol Cancer Ther. 2011;10:448–60.CrossRefPubMed McAndrew D, Grice DM, Peters AA, Davis FM, Stewart T, Rice M, et al. ORAI1-mediated calcium influx in lactation and in breast cancer. Mol Cancer Ther. 2011;10:448–60.CrossRefPubMed
48.
49.
go back to reference Michelangeli F, East JM. A diversity of SERCA Ca2+ pump inhibitors. Biochem Soc Trans. 2011;39:789–97.CrossRefPubMed Michelangeli F, East JM. A diversity of SERCA Ca2+ pump inhibitors. Biochem Soc Trans. 2011;39:789–97.CrossRefPubMed
50.
go back to reference Cao XH, Zhao SS, Liu DY, Wang Z, Niu LL, Hou LH, et al. ROS-Ca2+ is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosis. Chem Biol Interact. 2011;190:16–27.CrossRefPubMed Cao XH, Zhao SS, Liu DY, Wang Z, Niu LL, Hou LH, et al. ROS-Ca2+ is associated with mitochondria permeability transition pore involved in surfactin-induced MCF-7 cells apoptosis. Chem Biol Interact. 2011;190:16–27.CrossRefPubMed
51.
go back to reference Tyagi M, Patro BS, Chattopadhyay S. Mechanism of the malabaricone C-induced toxicity to the MCF-7 cell line. Free Radic Res. 2014;48:466–77.CrossRefPubMed Tyagi M, Patro BS, Chattopadhyay S. Mechanism of the malabaricone C-induced toxicity to the MCF-7 cell line. Free Radic Res. 2014;48:466–77.CrossRefPubMed
53.
go back to reference Rimessi A, Giorgi C, Pinton P, Rizzuto R. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim Biophys Acta. 1777;2008:808–16. Rimessi A, Giorgi C, Pinton P, Rizzuto R. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochim Biophys Acta. 1777;2008:808–16.
54.
go back to reference Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805–16.CrossRefPubMed Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75:805–16.CrossRefPubMed
55.
go back to reference Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A. 1995;92:8493–7.CrossRefPubMedPubMedCentral Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci U S A. 1995;92:8493–7.CrossRefPubMedPubMedCentral
56.
go back to reference Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene. 1995;10:2263–70.PubMed Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene. 1995;10:2263–70.PubMed
57.
go back to reference Matsunaga K, Yoshimi N, Yamada Y, Shimizu M, Kawabata K, Ozawa Y, et al. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn J Cancer Res. 1998;89:496–501.CrossRefPubMed Matsunaga K, Yoshimi N, Yamada Y, Shimizu M, Kawabata K, Ozawa Y, et al. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. Jpn J Cancer Res. 1998;89:496–501.CrossRefPubMed
58.
go back to reference Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM, Tseng TH. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol. 2000;74:467–72.CrossRefPubMed Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM, Tseng TH. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol. 2000;74:467–72.CrossRefPubMed
59.
go back to reference Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV, et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett. 1999;137:123–30.CrossRefPubMed Hecht SS, Kenney PM, Wang M, Trushin N, Agarwal S, Rao AV, et al. Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett. 1999;137:123–30.CrossRefPubMed
60.
go back to reference Yamada H, Watanabe K, Saito T, Hayashi H, Niitani Y, Kikuchi T, et al. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. J Rheumatol. 1999;26:654–62.PubMed Yamada H, Watanabe K, Saito T, Hayashi H, Niitani Y, Kikuchi T, et al. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. J Rheumatol. 1999;26:654–62.PubMed
61.
go back to reference Kim JS, Ha TY, Ahn J, Kim S. Analysis and distribution of esculetin in plasma and tissues of rats after oral administration. Prev Nutr Food Sci. 2014;19:321–6.CrossRefPubMedPubMedCentral Kim JS, Ha TY, Ahn J, Kim S. Analysis and distribution of esculetin in plasma and tissues of rats after oral administration. Prev Nutr Food Sci. 2014;19:321–6.CrossRefPubMedPubMedCentral
Metadata
Title
Esculetin, a natural coumarin compound, evokes Ca2+ movement and activation of Ca2+-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells
Authors
Hong-Tai Chang
Chiang-Ting Chou
You-Sheng Lin
Pochuen Shieh
Daih-Huang Kuo
Chung-Ren Jan
Wei-Zhe Liang
Publication date
01-04-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 4/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4286-1

Other articles of this Issue 4/2016

Tumor Biology 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine